179 related articles for article (PubMed ID: 29599333)
1. Frequency of the Loss of Heterozygosity of the
DE Carvalho RM; DE Castro Sant' Anna C; Pinto GR; Paschoal EHA; Tuji FM; DO Nascimento Borges B; Soares PC; Júnior AGF; Rey JA; Chaves LCL; Burbano RR
Anticancer Res; 2018 Apr; 38(4):2149-2154. PubMed ID: 29599333
[TBL] [Abstract][Full Text] [Related]
2. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas.
Hadfield KD; Smith MJ; Urquhart JE; Wallace AJ; Bowers NL; King AT; Rutherford SA; Trump D; Newman WG; Evans DG
Oncogene; 2010 Nov; 29(47):6216-21. PubMed ID: 20729918
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity on chromosome 22 in sporadic schwannoma and its relation to the proliferation of tumor cells.
Bian LG; Sun QF; Tirakotai W; Zhao WG; Shen JK; Luo QZ; Bertalanffy H
Chin Med J (Engl); 2005 Sep; 118(18):1517-24. PubMed ID: 16232328
[TBL] [Abstract][Full Text] [Related]
4. The neurofibromatosis type 2 gene is inactivated in schwannomas.
Twist EC; Ruttledge MH; Rousseau M; Sanson M; Papi L; Merel P; Delattre O; Thomas G; Rouleau GA
Hum Mol Genet; 1994 Jan; 3(1):147-51. PubMed ID: 8162016
[TBL] [Abstract][Full Text] [Related]
5. A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene.
Bruder CE; Ichimura K; Tingby O; Hirakawa K; Komatsuzaki A; Tamura A; Yuasa Y; Collins VP; Dumanski JP
Hum Genet; 1999 May; 104(5):418-24. PubMed ID: 10394935
[TBL] [Abstract][Full Text] [Related]
6. Neurofibromatosis 2 phenotypes and germ-line NF2 mutations determined by an RNA mismatch method and loss of heterozygosity analysis in NF2 schwannomas.
Hung G; Faudoa R; Baser ME; Xue Z; Kluwe L; Slattery W; Brackman D; Lim D
Cancer Genet Cytogenet; 2000 Apr; 118(2):167-8. PubMed ID: 10748301
[TBL] [Abstract][Full Text] [Related]
7. NF2 genetic alterations in sporadic vestibular schwannomas: clinical implications.
Lassaletta L; Torres-Martín M; Peña-Granero C; Roda JM; Santa-Cruz-Ruiz S; Castresana JS; Gavilan J; Rey JA
Otol Neurotol; 2013 Sep; 34(7):1355-61. PubMed ID: 23921927
[TBL] [Abstract][Full Text] [Related]
8. Double somatic SMARCB1 and NF2 mutations in sporadic spinal schwannoma.
Paganini I; Capone GL; Vitte J; Sestini R; Putignano AL; Giovannini M; Papi L
J Neurooncol; 2018 Mar; 137(1):33-38. PubMed ID: 29230670
[TBL] [Abstract][Full Text] [Related]
9. Mutations and allelic loss of the NF2 gene in neurofibromatosis 2-associated skin tumors.
Kluwe L; Friedrich RE; Hagel C; Lindenau M; Mautner VF
J Invest Dermatol; 2000 May; 114(5):1017-21. PubMed ID: 10771486
[TBL] [Abstract][Full Text] [Related]
10. Frequency of loss of heterozygosity of the NF2 gene in schwannomas from Croatian patients.
Pećina-Slaus N; Zeljko M; Pećina HI; Nikuseva Martić T; Bacić N; Tomas D; Hrasćan R
Croat Med J; 2012 Aug; 53(4):321-7. PubMed ID: 22911524
[TBL] [Abstract][Full Text] [Related]
11. Allelic expression of the NF2 gene in neurofibromatosis 2 and schwannomatosis.
Jacoby LB; MacCollin M; Parry DM; Kluwe L; Lynch J; Jones D; Gusella JF
Neurogenetics; 1999 Apr; 2(2):101-8. PubMed ID: 10369886
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of NF2 and NF1 tumor suppressor genes in distinctive gastrointestinal nerve sheath tumors traditionally diagnosed as benign schwannomas: s study of 20 cases.
Lasota J; Wasag B; Dansonka-Mieszkowska A; Karcz D; Millward CL; Ryś J; Stachura J; Sobin LH; Miettinen M
Lab Invest; 2003 Sep; 83(9):1361-71. PubMed ID: 13679444
[TBL] [Abstract][Full Text] [Related]
13. Genetic aberrations in sporadic and neurofibromatosis 2 (NF2)-associated schwannomas studied by comparative genomic hybridization (CGH).
Antinheimo J; Sallinen SL; Sallinen P; Haapasalo H; Helin H; Horelli-Kuitunen N; Wessman M; Sainio M; Jääskeläinen J; Carpén O
Acta Neurochir (Wien); 2000; 142(10):1099-104; discussion 1104-5. PubMed ID: 11129530
[TBL] [Abstract][Full Text] [Related]
14. Comparative genomic hybridization and mutation analyses of sporadic schwannomas.
Ikeda T; Hashimoto S; Fukushige S; Ohmori H; Horii A
J Neurooncol; 2005 May; 72(3):225-30. PubMed ID: 15937644
[TBL] [Abstract][Full Text] [Related]
15. Allelic status of 1p, 14q, and 22q and NF2 gene mutations in sporadic schwannomas.
Leone PE; Bello MJ; Mendiola M; Kusak ME; De Campos JM; Vaquero J; Sarasa JL; Pestana A; Rey JA
Int J Mol Med; 1998 May; 1(5):889-92. PubMed ID: 9852312
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis.
Jacoby LB; Jones D; Davis K; Kronn D; Short MP; Gusella J; MacCollin M
Am J Hum Genet; 1997 Dec; 61(6):1293-302. PubMed ID: 9399891
[TBL] [Abstract][Full Text] [Related]
17. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas.
Antinheimo J; Sankila R; Carpén O; Pukkala E; Sainio M; Jääskeläinen J
Neurology; 2000 Jan; 54(1):71-6. PubMed ID: 10636128
[TBL] [Abstract][Full Text] [Related]
18. Segmental neurofibromatosis type 2: discriminating two hit from four hit in a patient presenting multiple schwannomas confined to one limb.
Castellanos E; Bielsa I; Carrato C; Rosas I; Solanes A; Hostalot C; Amilibia E; Prades J; Roca-Ribas F; Lázaro C; Blanco I; Serra E;
BMC Med Genomics; 2015 Jan; 8():2. PubMed ID: 25739810
[TBL] [Abstract][Full Text] [Related]
19. Loss of the NF2 gene and merlin occur by the tumorlet stage of schwannoma development in neurofibromatosis 2.
Stemmer-Rachamimov AO; Ino Y; Lim ZY; Jacoby LB; MacCollin M; Gusella JF; Ramesh V; Louis DN
J Neuropathol Exp Neurol; 1998 Dec; 57(12):1164-7. PubMed ID: 9862639
[TBL] [Abstract][Full Text] [Related]
20. Multiple schwannomas: schwannomatosis or neurofibromatosis type 2?
Seppälä MT; Sainio MA; Haltia MJ; Kinnunen JJ; Setälä KH; Jääskeläinen JE
J Neurosurg; 1998 Jul; 89(1):36-41. PubMed ID: 9647170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
